《用于卵巢癌同步磁共振成像与化疗的促黄体生成素释放激素靶向顺铂负载磁铁矿纳米簇》的更正
Correction to "Luteinizing Hormone Releasing Hormone-Targeted Cisplatin-Loaded Magnetite Nanoclusters for Simultaneous MR Imaging and Chemotherapy of Ovarian Cancer".
作者信息
Vishwasrao Hemant M, Master Alyssa M, Seo Youn Gee, Liu Xinming M, Pothayee Nikorn, Zhou Zhengyuan, Yuan Dongfen, Boska Michael D, Bronich Tatiana K, Davis Richey M, Riffle Judy S, Sokolsky-Papkov Marina, Kabanov Alexander V
出版信息
Chem Mater. 2021 Sep 28;33(18):7566-7567. doi: 10.1021/acs.chemmater.1c02828. Epub 2021 Sep 8.
Abstract
[This corrects the article PMC10317193.].
摘要
[本文对文章PMC10317193进行了修正。]
相似文献
1
Correction to "Luteinizing Hormone Releasing Hormone-Targeted Cisplatin-Loaded Magnetite Nanoclusters for Simultaneous MR Imaging and Chemotherapy of Ovarian Cancer".《用于卵巢癌同步磁共振成像与化疗的促黄体生成素释放激素靶向顺铂负载磁铁矿纳米簇》的更正
Chem Mater. 2021 Sep 28;33(18):7566-7567. doi: 10.1021/acs.chemmater.1c02828. Epub 2021 Sep 8.
2
Luteinizing Hormone Releasing Hormone-Targeted Cisplatin-Loaded Magnetite Nanoclusters for Simultaneous MR Imaging and Chemotherapy of Ovarian Cancer.用于卵巢癌同步磁共振成像和化疗的促黄体生成素释放激素靶向顺铂负载磁铁矿纳米簇
Chem Mater. 2016 May 10;28(9):3024-3040. doi: 10.1021/acs.chemmater.6b00197. Epub 2016 May 2.
3
Targeted cytotoxic analog of luteinizing hormone-releasing hormone AN-207 inhibits growth of OV-1063 human epithelial ovarian cancers in nude mice.促黄体生成素释放激素靶向细胞毒性类似物AN-207抑制裸鼠体内OV-1063人上皮性卵巢癌的生长。
Am J Obstet Gynecol. 1999 May;180(5):1095-103. doi: 10.1016/s0002-9378(99)70600-9.
4
Antitumor effects of the cytotoxic luteinizing hormone-releasing hormone analog AN-152 on human endometrial and ovarian cancers xenografted into nude mice.细胞毒性促黄体生成素释放激素类似物AN-152对移植到裸鼠体内的人子宫内膜癌和卵巢癌的抗肿瘤作用。
Am J Obstet Gynecol. 2002 Sep;187(3):528-37. doi: 10.1067/mob.2002.124278.
5
Luteinizing hormone-releasing hormone agonists in premenopausal hormone receptor-positive breast cancer.绝经前激素受体阳性乳腺癌中的促黄体生成素释放激素激动剂
Clin Breast Cancer. 2007 Feb;7(6):455-64. doi: 10.3816/CBC.2007.n.002.
6
Expression of receptors for luteinizing hormone-releasing hormone in human ovarian and endometrial cancers: frequency, autoregulation, and correlation with direct antiproliferative activity of luteinizing hormone-releasing hormone analogues.促黄体生成激素释放激素受体在人卵巢癌和子宫内膜癌中的表达：频率、自身调节以及与促黄体生成激素释放激素类似物直接抗增殖活性的相关性
Am J Obstet Gynecol. 2002 Feb;186(2):171-9. doi: 10.1067/mob.2002.119633.
7
Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta-analysis of randomized studies.化疗中使用促黄体生成素释放激素激动剂抑制卵巢功能以保留乳腺癌患者的卵巢功能和生育能力：一项随机研究的荟萃分析。
Ann Oncol. 2015 Dec;26(12):2408-19. doi: 10.1093/annonc/mdv374. Epub 2015 Sep 7.
8
Luteinizing hormone-releasing hormone targeted superparamagnetic gold nanoshells for a combination therapy of hyperthermia and controlled drug delivery.靶向黄体生成素释放激素的超顺磁性金纳米壳用于热疗和可控药物递送的联合治疗。
Mater Sci Eng C Mater Biol Appl. 2017 Jul 1;76:692-700. doi: 10.1016/j.msec.2017.03.162. Epub 2017 Mar 20.
9
Ovarian tumor targeting of docetaxel-loaded liposomes mediated by luteinizing hormone-releasing hormone analogues. In vive distribution in nude mice.促黄体生成素释放激素类似物介导的载多西他赛脂质体对卵巢肿瘤的靶向作用。在裸鼠体内的分布。
Arzneimittelforschung. 2008;58(10):529-34. doi: 10.1055/s-0031-1296553.
10
Gonadal function of patients treated with cisplatin based chemotherapy for germ cell cancer.接受基于顺铂化疗的生殖细胞癌患者的性腺功能。
J Urol. 1997 Sep;158(3 Pt 1):844-50. doi: 10.1097/00005392-199709000-00041.
Zotero 插件